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There has been increasing recognition regarding the impor-tance of right ventricular (RV) dysfunction as an indepen-
dent determinant of poor prognosis and exercise intolerance 
in patients with left-sided heart failure.1–7 In particular, RV 
function correlates better with exercise capacity than left ven-
tricular function.4,8 There are several potential mechanisms 
that may contribute to deteriorating RV that may ultimately 
become dysfunctional in association with left ventricular 
(LV) failure. First, it can suffer from the same cardiomyop-
athic process as the left ventricle. Second, decreased coronary
perfusion, LV dilatation in a limited pericardial compartment
(ventricular interdependence), and septal dysfunction can all
alter RV systolic and diastolic properties. Finally, LV failure
can directly increase RV afterload through a passive (pul-
monary venous pressure elevation) and reactive (pulmonary
vasoconstriction and remodeling) component, thus putting the
afterload-sensitive RV at increased risk of failure even in the
absence of intrinsic damage.9,10 It is however unclear whether
pulmonary vascular resistance (PVR) is the best reﬂection of
RV afterload in the setting of left-sided heart failure.
Pulmonary arterial capacitance (PAC), deﬁned as the 
ratio of stroke volume over pulmonary pulse pressure, is a 
recently proposed determinant of RV afterload. It represents 
the distensibility of the pulmonary arterial tree and has shown 
to be a better predictor of mortality than PVR in pulmonary 
arterial hypertension (PAH).11,12 Likewise, the importance 
of compliance, as a predictor of adverse events, has been 
demonstrated in the systemic circulation. In healthy individuals 
and in patients with PAH, it has been demonstrated that PVR 
and PAC are inversely related in such way that their product 
forms a constant.13 This even holds true during treatment 
for PAH.14–16 This implies that early in the course of PAH, 
small increases in PVR are accompanied by large decreases 
in PAC, likely accounting for the superior prognostic ability 
of the latter. In PAH however, the primary pathology lies in 
the remodeling of the small arteries and arterioles, whereas 
in heart failure the primary pathology is localized in the left 
ventricle with subsequent rise in ﬁlling pressures. Remodeling 
or constriction of small pulmonary arteries are possibilities, 
but not requisites. Very recently, Tedford et al described 
the inﬂuence of wedge pressure and age on the relationship 
between PAC and PVR.17
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The aims of this study were: (1) To determine relationships 
between PAC and various clinical, hemodynamic, and echo-
cardiographic variables; (2) To investigate whether the inverse 
relationship between PAC and PVR remains valid in the set-
ting of (left-sided) heart failure; (3) To test which afterload 
measure (PVR or PAC) best correlates with RV failure; (4) 
To test which afterload measure (PVR or PAC) best predicts 
outcomes; and (5) To determine whether PAC is modiﬁable 
during treatment of acute decompensated heart failure.
Methods
Study Population
We reviewed clinical information for all consecutive patients aged 
18 years or older with advanced chronic (>6 months) heart failure 
who underwent right heart catheterization between January 1, 2000 
and August 31, 2005 in the Cleveland Clinic cardiac catheterization 
laboratory. The primary indication for right heart catheterization was 
worsening heart failure symptoms or as part of a workup for heart 
transplant candidacy. Patients were excluded if they had a diagnosis 
of PAH, were on chronic inotropic drug infusions or had complex 
congenital heart disease.
To explore whether PAC could be modiﬁed during treatment, we 
examined a separate cohort of consecutive acute decompensated 
heart failure patients admitted to the Cleveland Clinic for hemody-
namically tailored therapy between December 1, 2010 and September 
30, 2011. We included all patients whose pulmonary capillary wedge 
pressure (PCWP) decreased 10 mm Hg or more during treatment 
on serial measurements. The Cleveland Clinic Institutional Review 
Board has approved this study.
Hemodynamic Assessment
Right heart catheterization was done in the catheterization laboratory 
at rest in the supine position. The procedure was performed by a heart 
failure fellow in the presence of a member of the heart failure staff 
cardiologist. The internal venous jugular approach was commonly 
used. A balloon-tipped catheter was used to obtain mean right atrial 
pressure, pulmonary artery systolic and diastolic pressures, as well as 
PCWP. All measurements were obtained at end expiration at steady 
state with the patient in a supine position. PCWP was calculated by 
the computer as the integrated mean. Mixed central venous blood gas 
was sampled from the pulmonary artery. Cardiac output was mea-
sured by assumed Fick equation. PVR and systemic vascular resis-
tance, cardiac index, stroke volume, and transpulmonary gradient 
were calculated using the standard formulas. Systolic and diastolic 
blood pressures were obtained using a digital sphygmomanometer at 
the time of the procedure. PAC is directly related to the volume of 
forward ﬂow (ie, stroke volume) and inversely proportional to the 
pulmonary artery pulse pressure (ie, difference between pulmonary 
artery systolic and diastolic pressures), according to the following 
equation: PAC=Stroke volume/pulse pressure and expressed in mL/
mm Hg. The product of resistance and capacitance (PVR×PAC) is 
referred to as the pulmonary arterial time constant τ.
Besides the hemodynamic variables, demographic characteristics, 
medical history, medical treatment, implanted devices, and echo-
cardiographic parameters (if done within 30 days before the cath-
eterization procedure) were also collected. LV ejection fraction was 
measured by biplane Simpson’s method, mitral and tricuspid regur-
gitation were semiqualitatively graded by color-ﬂow Doppler in the 
conventional parasternal long-axis and apical 4-chamber images: 
minimal: 1+ (jet area/left atrial area <10%); moderate: 2+ (jet area/
left atrial area 10%–20%); moderate-severe: 3+ (jet area/left atrial 
area 20%– 45%); or severe: 4+ (jet area/left atrial area >45%). RV 
systolic dysfunction was visually assessed on a scale of 0 to 4, with 0 
being normal and 4 being severely hypokinetic RV wall motion. RV 
failure was deﬁned as grade 3 or 4 hypokinetic motion.
The duration of follow-up was deﬁned as the interval from the in-
dex right heart catheterization date to December 31, 2006. Manual 
chart review for all-cause mortality and transplantation was per-
formed, and review of the Social Security Death Index conﬁrmed 
the death status. All-cause mortality and cardiac transplantation were 
combined as the prespeciﬁed primary outcome for survival analysis.
For the second set of patients with serial assessment, 2 sets of he-
modynamics (on admission and at time of pulmonary artery catheter 
removal) were used for this analysis. The hemodynamic values were 
documented in the chart by other cardiologists who were unaware of 
the present study, after careful leveling of the transducer. In addition, 
demographics and treatment data were abstracted from the chart.
Statistical Methods
The data are expressed as mean±SD for continuous data and as a 
percentage for categorical data. Comparisons are made with the use 
of the Student t test or Wilcoxon rank sum test. A paired t test was 
used to detect changes in PVR, PAC, or τ after treatment. The distri-
bution of PAC was asymmetric and therefore expressed as median 
and interquartile range. Spearman correlation coefﬁcients were used 
to assess the univariate relationships between PVR/PAC and clini-
cal, hemodynamic, and echocardiographic variables. To demonstrate 
the relationship between PVR and PAC, a nonlinear curve was ﬁtted 
according to the formula y=cte/x (hyperbola formula). Receiver op-
erating characteristic (ROC) curves were constructed to examine the 
association between different afterload measures and coinciding RV 
failure. The Cox proportional hazards regression model was used to 
determine which variables were signiﬁcant predictors for all-cause 
mortality and cardiac transplantation during the mean 3.2±2.2 years 
follow-up period. A multivariate model was constructed using well-
known predictors of adverse outcomes in heart failure (age, New York 
Heart Association [NYHA] class, RV function, cardiac index, and 
glomerular ﬁltration rate) in addition to one of the afterload param-
eters. Study population was stratiﬁed into PAC and PVR quartiles to 
facilitate identiﬁcation of high and low risk patients by Kaplan-Meier 
survival analysis. Statistical signiﬁcance was set at a 2-tailed prob-
ability level of <0.05. All analyses were performed with SAS version 
9.1 and JMP version 5.1 (SAS Institute Inc, Cary, NC). The authors 
had full access to the data and take responsibility for its integrity. All 
authors have read and agreed to the manuscript as written.
Results
Baseline Characteristics
A total of 724 patients, for whom hemodynamic data were 
available, underwent right heart catheterization between Janu-
ary 1, 2000 and August 31, 2005. The mean and median PAC 
was, respectively, 3.07±2.05 mL/mm Hg and 2.5 (interquar-
tile range 1.60–3.96) mL/mm Hg. Table 1 shows the baseline 
characteristics of our study cohort stratiﬁed according to those 
above versus below median PAC levels. Patients with reduced 
PAC were older, had more impaired hemodynamics and 
impaired cardiac performance by echocardiography (available 
in 650 patients, 90%).
Correlations Between PAC, PVR, and 
Other Variables
Table 2 illustrates correlations between PAC, PVR, and various 
clinical, hemodynamic, and echocardiographic variables in 
our study cohort. PAC highly correlates with PCWP (r=−0.73, 
P<0.0001) and mean pulmonary artery pressure (r=−0.81, 
P<0.0001). The correlation coefﬁcients of PAC were larger (in 
absolute magnitude) than those of PVR when correlated with 
different measures of RV failure such as RV dysfunction class 
(r=−0.46 versus r=0.32), tricuspid insufﬁciency (r=−0.37 
versus r=0.25), and right atrial pressure (r=−0.51 versus 
r=0.31). As expected, there is a strong, although not perfect, 
negative correlation between the 2 afterload measures PAC and 
PVR (r=−0.66, P<0.0001). Figure 1 plots PAC as a function of 
PVR and demonstrates their hyperbolic relationship. However, 
the exact shape of the hyperbola, and thus the pulmonary 
arterial time constant τ=PVR×PAC, decreases with increasing 
wedge pressure (r=−0.42, P<0.0001) (Figures 1 and 2). When 
dichotomized at a wedge pressure of ≤ or >17 mm Hg, the 
mean pulmonary arterial time constant τ decreases from 
0.43 to 0.30 seconds. Of note, the correlation between mean 
pulmonary pressure and τ (r=−0.11) is much lower than the 
correlation between wedge pressure and τ.
Association of RV Failure With Different  
Afterload Measures
RV failure, as deﬁned by echocardiographic dysfunction 
grade 3 or more, was very frequent (312/650 patients [48%] 
with available echocardiograms). The association of PAC with 
Table 1. Baseline Patient Characteristics Stratiﬁed According to Median PAC Levels
Total Population (n=724) PAC >2.5 mL/mm Hg (n=362) PAC ≤2.5 mL/mm Hg (n=362) P
Baseline clinical data
Age, y 55±11 53±12 56±11 <0.0001
Sex (% male) 77 77 78 1.00
Ischemic pathogenesis, % 50 49 51 0.43
Body mass index, kg/m2 28±5 29±6 27±5 0.0036
Diabetes mellitus, % 28 24 31 0.031
Hemodynamic data
Heart rate, bpm 81±19 78±18 84±19 <0.0001
Mean arterial pressure, mm Hg 85±13 84±12 87±13 0.0053
Mean RA pressure, mm Hg 8.9±5.9 6.6±5.1 11.2±5.7 <0.0001
Mean PA pressure, mm Hg 30±11 22±8 37±9 <0.0001
Pulse pressure, mm Hg 24±10 17±6 31±9 <0.0001
PCWP, mm Hg 19±9 14±7 25±7 <0.0001
Transpulmonary gradient, mm Hg 10.4±5.9 8.1±4 12.6±7 <0.0001
Fick cardiac index, L·min–1·m–2 2.3±0.6 2.6±0.6 2.0±0.5 <0.0001
Stroke volume 59±20 70±20 48±14 <0.0001
PVR, dynes·s–1·cm–5 208±141 138±72 279±158 <0.0001
SVR, dynes·s–1·cm–5 1496±468 1324±394 1670±473 <0.0001
RVSWI, mL·mm Hg–1·m–2 578±263 507±231 648±275 <0.0001
Echocardiographic data
LV ejection fraction, % 19±9 21±10 17±8 <0.0001
LV end-diastolic diameter, mm 6.6±1.1 6.5±1.1 6.7±1.1 0.018
RV function class ≥3+, % 48 29 66 <0.0001
RV systolic pressure, mm Hg 46±17 34±10 58±13 <0.0001
Mitral regurgitation ≥3+, % 33 23 43 <0.0001
Tricuspid regurgitation ≥3+, % 19 12 25 <0.0001
Medications
ACE inhibitor or ARBs, % 86 87 84 0.04
β-blockers, % 69 72 66 0.11
Loop diuretics, % 92 89 95 0.004
Aldosterone antagonists, % 37 34 39 0.14
Device data
ICD, % 38 38 38 0.93
 CRT-D, % 9 7 10 0.18
Laboratory data
eGFR (mL·mm Hg–1·m–2, n=664) 71±28 74±28 68±27 0.008
BNP (pg/mL, n=207) 730±872 476±818 981±845 <0.0001
Hemoglobin (g/dL, n=667) 13.4±1.8 13.6±1.6 13.1±1.9 0.0004
PAC indicates pulmonary arterial capacitance; bpm, beats per minute; RA, right atrial; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure; PVR, 
pulmonary vascular resistance; SVR, systemic vascular resistance; RVSWI, right ventricular stroke work index; LV, left ventricular; RV, right ventricular; ACE, angiotensin-
converting enzyme; ARB, angiotensin receptor blocker; ICD, implantable cardioverter-deﬁbrillator; CRT-D, cardiac resynchronization therapy with deﬁbrillator; eGFR, 
estimated glomerular ﬁltration rate; BNP, B-type natriuretic peptide.
RV failure (area under the curve ROC=0.74) was superior 
to the association of PVR (area under the curve ROC=0.67, 
P=0.003) with RV failure. In comparison, the area under the 
curve ROC for wedge pressure is 0.71 (P=0.11 with PAC). 
Patients with PAC below the median (<2.5 mL/mm Hg) and 
PVR above the median (>170 dynes∙s–1∙cm–5 =2.1 WU) have 
an OR of 6.45 (4.35–9.67, P<0.0001) of having RV failure 
compared with patients with high PAC (above median) and 
low PVR (below median). If PVR was high with preserved 
PAC (above median), the OR was 1.94 (1.14–3.28, P=0.02). 
However, when PAC was low with preserved PVR (below 
median), the OR was 4.45 (2.58–7.80, P<0.0001) again 
underscoring the importance of PAC.
Predictive Capacity of PAC and PVR for  
Adverse Events
The follow-up period ended at December 31, 2006, after a median 
follow-up of a little more than 3 years (1130 days [interquartile 
range 382–1883 days]). A total of 224 deaths (31%) and 163 
transplants (23%) had occurred. Overall, decreasing quartiles of 
PAC, PVR, and PCWP were all associated with increasing rates 
of death or transplantation (Figure 3; log-rank P<0.0001). In 
univariate Cox proportional hazard modeling, PAC was a stronger 
predictor of all-cause mortality or transplantation than PVR 
(C-statistic 0.69 versus 0.64, P=0.02), whereas the C-statistic for 
PCWP was 0.67 (P=0.21 with PAC). In multivariable analysis, 
PAC (but not PVR) remained an independent predictor of 
adverse clinical events even after adjusting for various clinical, 
hemodynamic, and echocardiographic variables including age, 
NYHA class, Fick CI, RV function, and estimated glomerular 
ﬁltration rate (Table 3). Fick cardiac index, estimated glomerular 
ﬁltration rate, and RV systolic function, however, were the 
strongest predictors of death or transplantation.
The Inﬂuence of Treatment on PAC, PVR, and τ
A total of 208 patients were admitted for hemodynamically 
tailored therapy between December 1, 2010 and Septem-
ber 30, 2011. Hundred and eighty patients had a PCWP 
Table 2. Spearman Correlation Coefﬁcients Between PAC and PVR on One Hand and Various Clinical, 
Hemodynamic, and Echocardiographic Variables on the Other
PAC PVR
Correlation Coefﬁcient P Correlation Coefﬁcient P
Baseline clinical data
Age, y −0.21 <0.0001 0.16 <0.0001
Body mass index, kg/m2 0.20 <0.0001 −0.15 <0.0001
NYHA class −0.24 <0.0001 0.12 0.0009
Hemodynamic data
Heart rate, bpm −0.22 <0.0001 0.09 0.01
Mean arterial pressure, mm Hg −0.09 0.019 0.05 0.16
Mean RA pressure, mm Hg −0.51 <0.0001 0.31 <0.0001
Mean PA pressure, mm Hg −0.81 <0.0001 0.62 <0.0001
Pulse Pressure, mm Hg −0.84 <0.0001 0.53 <0.0001
PCWP, mm Hg −0.73 <0.0001 0.31 <0.0001
Transpulmonary gradient, mm Hg −0.44 <0.0001 0.88 <0.0001
Fick cardiac index, L·min–1·m–2 0.55 <0.0001 −0.40 <0.0001
Stroke volume 0.67 <0.0001 −0.45 <0.0001
PAC, ml/mm Hg −0.64 <0.0001
PVR, dynes·s–1·cm–5 −0.64 <0.0001
SVR, dynes·s–1·cm–5 −0.49 <0.0001 0.42 <0.0001
RVSWI, mL·mm Hg–1·m–2 −0.25 <0.0001 0.30 <0.0001
Echocardiographic data
LV ejection fraction, % 0.29 <0.0001 −0.19 <0.0001
LV end-diastolic diameter, mm −0.10 0.014 0.04 0.31
RV systolic dysfunction class −0.46 <0.0001 0.32 <0.0001
Mitral regurgitation severity −0.19 <0.0001 0.19 <0.0001
Tricuspid regurgitation severity −0.37 <0.0001 0.25 <0.0001
Laboratory data
eGFR (mL·min–1·m–2, n=664) 0.17 <0.0001 −0.12 0.002
BNP (pg/mL, n=207) −0.57 <0.0001 0.35 <0.0001
Hemoglobin (g/dL, n=667) 0.13 0.0007 −0.03 0.39
PAC indicates pulmonary arterial capacitance; PVR, pulmonary vascular resistance; bpm, beats per minute; RA, right atrial; PA, pulmonary arte-
rial; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; RVSWI, right ventricular stroke work index; LV, left ventricu-
lar; RV, right ventricular; eGFR, estimated glomerular ﬁltration rate; BNP, B-type natriuretic peptide.
documented at baseline and at time of catheter removal. 
Seventy-ﬁve of those had a decrease in PCWP>10 mm Hg. 
Table 4 shows demographic characteristics, hemodynamic 
variables, and received treatment during admission for 
this cohort. Figure 4 demonstrates how during treatment, 
PVR decreases (0.20±0.12 to 0.16±0.07 mm Hg∙s–1·mL–1, 
P=0.002; 270±165 to 211±88 dynes·s–1·cm–5) and how 
PAC increases even more (1.6±0.64 to 2.61±1.42 mL/mm 
Hg, P<0.0001), resulting in a higher pulmonary arterial 
time constant τ in most patients (0.29±0.12 to 0.37±0.15, 
P<0.0001).
Discussion
The key ﬁnding of this study is that PAC, an integrated mea-
sure of RV afterload, may be superior to PVR in explaining 
RV failure and in predicting adverse outcomes in the setting 
of left-sided heart failure. The reason for this resides in the 
quality of PAC to combine the effects of PVR and PCWP on 
RV afterload. Furthermore, treatment with intensive medical 
therapy is associated with a favorable shift in PAC.
The afterload concept is daily used by clinicians while 
treating patients with left-, right- or biventricular failure. 
Although conceptualized as the load the ventricle experi-
ences during contraction, afterload is much more difﬁcult 
to measure and quantify. Pressures do not account for ﬂow 
and because the heart is a pulsatile, and not a continuous-
ﬂow pump, resistance is not sufﬁcient to describe afterload. 
The most widely accepted model to describe the hydraulic 
afterload is the so-called 3-element windkessel model which 
combines the resistance (R) of the small arteries and arteri-
oles with the elastic properties (compliance or capacitance 
[C]) of the whole arterial system and with the character-
istic impedance (Z) of the blood and proximal artery.18,19 
PVR bundles R and Z and is the most often used measure 
of RV afterload in clinical practice. The attraction of this 
model lies in the fact that the parameters are fairly easy to 
Figure 1. Inﬂuence of wedge pressure on the hyperbolic rela-
tionship between PAC and PVR. Pulmonary arterial capacitance 
(PAC) and pulmonary vascular resistance (PVR) relate in such 
way that their product forms a constant: PAC×PVR=cte which 
equals PAC=cte/PVR, the formula of a hyperbola. The value of 
the cte represents the pulmonary arterial time constant. In the 
total cohort, the cte which best ﬁts the datapoints is 0.35. How-
ever, the value of the pulmonary arterial time constant and so the 
shape of the hyperbola depends on wedge pressure. The higher 
the wedge pressure, the lower the time constant as illustrated (H0 
2 hyperbola’s are similar: P<0.0001).
Figure 2. Pulmonary arterial time constant as a function of 
wedge pressure. The pulmonary arterial time constant τ (sec-
ond) is the product of the pulmonary vascular resistance (PVR), 
expressed in mm Hg·s–1·mL–1, times pulmonary arterial capaci-
tance expressed in ml/mm Hg. Spearman’s correlation coef-
ﬁcient between wedge pressure and time constant is −0.42. 
The pulmonary arterial time constant is predicted by the formula 
τ=0.52–0.0085×wedge pressure.
Figure 3. Clinical outcomes according to PAC and PVR quartiles. A, According to PAC quartiles. B, According to PVR quartiles.  
C, According to PCWP quartiles. Log-rank <0.0001 for both. PAC indicates pulmonary arterial capacitance; PVR, pulmonary vascular 
resistance; PCWP, pulmonary capillary wedge pressure.
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measure, have physiologic meaning, and are straightforward 
to interpret.
The capacitance or compliance of the pulmonary circulation 
is dependent on vessel wall elasticity but also on vessel wall 
diameter and the latter in an exponential way. In other words, 
when the diameter of the pulmonary vessels increases, 
compliance will decrease to a much larger aspect. In addition 
and different from the systemic circulation, compliance is 
distributed over the entire pulmonary arterial bed owing to the 
large number of peripheral vessels. The latter 2 particularities 
form the base of the constant product of PVR and PAC 
(pulmonary arterial time constant τ) between individuals and 
during treatment observed in PAH patients.14 Indeed, whenever 
PVR increases, elevations in intravascular pressure will result, 
leading to stiffer arteries and reduced compliance. Even so, when 
part of the pulmonary arterial tree is lost because of an embolus, 
resistance will increase and compliance will decrease.20 This 
interdependence of PVR and PAC is different from the systemic 
circulation where resistance and compliance are anatomically 
more separated and can evolve independent from each other (eg, 
systolic hypertension of the elderly attributable to a decrease in 
compliance of the proximal arteries).
In contrast to PAH, where an increase in PVR constitutes 
the primary pathology, elevations in PVR are only optional in 
left-sided heart failure and the result of either vasoconstric-
tion or smooth muscle proliferation secondary to elevated left-
sided ﬁlling pressures (backward failure). Also in contrast to 
PAH, wedge pressure is highly variable within and between 
patients, changes during treatment, and is a major determinant 
of pulmonary intravascular pressure and consequently of PAC. 
Because increases in wedge pressure lower PAC but do not 
necessarily increase PVR, the pulmonary arterial time constant 
decreases with increasing wedge pressure. The hyperbolic 
relationship between PVR and PAC is still recognized, but the 
exact position is dependent on wedge pressure (Figure 1).
We hypothesize that the observed superior prognostic abil-
ity of PAC over PVR is explained by the representation of 
2 hemodynamic effects (those of PVR and wedge pressure) 
in 1 measure, namely PAC. This adds to the classic expla-
nation in PAH, where PAC is believed to be more sensitive 
especially early in the disease process when small increases 
in PVR result in large decreases in PAC.11,14 Because the heart 
failure population is very heterogeneous, the absolute strength 
of outcome prediction of PAC is less evident than in the PAH 
population where patients mainly die from RV failure.
The overall better performance of PAC does not alter 
the speciﬁc importance of increased PVR in a subgroup of 
Table 3. Multivariate Cox Proportional Hazard Model For 
Death or Transplantation
Predictors
Hazard Ratio* forDeath 
or Transplant P
NYHA (class) 1.09 (0.85–1.40) 0.50
Age, y 0.97 (0.92–1.16) 0.53
Fick, L·min–1·m–2 0.56 (0.44–0.72) <0.0001
PAC, mL/mm Hg 0.92 (0.84–1.0) 0.037
RV function (class) 1.18 (1.06–1.31) 0.0019
eGFR, mL·min–1·1.73 m–2 0.90 (0.85–0.94) <0.0001
When PAC was exchanged for PVR in this model, the P-value of PVR was 
only 0.69.
NYHA indicates PAC, pulmonary arterial capacitance; RV, right ventricular; 
eGFR, estimated glomerular ﬁltration rate.
*Hazard ratio per 1 increment for NYHA class, Fick index, PAC and RV
function. Per 10 increment for age and eGFR.
Table 4. Demographics, Hemodynamics, and Medical 
Treatment of 75 Patients Admitted With ADHF
Treatment Cohort (n=75)
Baseline clinical data
Age, y 57±13
Sex (% male) 78
Ischemic pathogenesis, % 47
Body mass index, kg/m2 29±6
Diabetes mellitus, % 44
Left ventricular EF, % 24±13
Atrial ﬁbrillation, % 28
Baseline hemodynamic data
Heart rate baseline, bpm 87±18
Mean arterial pressure baseline, mm Hg 82±13
Mean RA pressure baseline, mm Hg 18±6
Mean PA pressure baseline, mm Hg 43±9
PCWP baseline, mm Hg 31±7
Fick cardiac index baseline, L·min–1·m–2 1.84±0.64
Follow-up hemodynamic data
Heart rate FU, bpm 86±15
Mean arterial pressure FU, mm Hg 75±8
Mean RA pressure FU, mm Hg 9±9
Mean PA pressure FU, mm Hg 29±6
PCWP FU, mm Hg 16±5
Fick cardiac index FU, L·min–1·m–2 2.67±0.83
Medications
ACE inhibitor or ARBs, % 72
β-blockers, % 72
Loop diuretics, % 99
Aldosterone antagonists, % 56
Nitroprusside, % 75
Hydralazine, % 74
Isosorbide dinitrate, % 66
Milrinone, % 28
Dobutamine, % 24
 IABP, % 7
Device data
ICD, % 59
 CRT-D, % 21
Laboratory data
Creatinine, mg/dL 1.52±0.69
ADHF indicates acute decompensated heart failure; EF, ejection fraction; RA, 
right atrial; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure; 
FU, follow-up (time of catheter removal); ACE, angiotensin-converting enzyme; 
ARB, angiotensin receptor blocker; IABP, intra-aortic balloon pump; ICD, im-
plantable cardioverter- deﬁbrillator; CRT-D, cardiac resynchronization therapy 
with deﬁbrillator.
patients. It was recently demonstrated that patients with 
reactive or so-called out-of-proportion pulmonary hyperten-
sion (deﬁned as mPAP>25 mm Hg, PCWP>15 mm Hg and 
PVR>3WU) have a particularly worse prognosis.10 Moreover, 
the passive (increase in wedge pressure) component to RV 
afterload is more easily correctable by medical treatment or 
even heart transplantation than the reactive component. PVR 
will keep playing an important role, for example in determin-
ing eligibility for heart transplantation.
The above discussion concentrated on how PAC is 
inﬂuenced by increased vessel wall diameter because of either 
increased PVR or wedge pressure. The question remains how 
the quality of the vessel wall itself inﬂuences PAC and whether 
interindividual variations are clinically meaningful as is the case 
in the systemic circulation. The remarkable consistency and 
similarity of τ in patients with PAH made authors believe that 
there is little or no structural change in the elastic properties of 
the pulmonary arterial circulation.13 Very recently, Tedford et 
al17 found a small but signiﬁcant inﬂuence of age on τ . There is 
indeed some evidence that structural changes in the pulmonary 
arterial circulation occur with increasing age.21,22 Similar to our 
study, they found a very signiﬁcant inﬂuence of PCWP on τ, a 
relationship described by the formula τ=0.46–0.0063×wedge 
pressure which is remarkably similar than the formula found in 
the present study (τ=0.52–0.0085×wedge pressure). However, 
in our study, there is still considerable variation in τ for every 
given wedge pressure (see ﬁgure 2) which might be explained 
in part by inaccurate measurements (eg, catheter wip), the 
effect of large v-waves on the wedge pressure (calculated as the 
integrated mean) and age, as discussed. In addition it remains 
possible that other unappreciated factors inﬂuence the inverse 
PVR–PAC relationship. The ﬁnding that PCWP augments the 
pulsatile load on the afterload-sensitive right ventricle and 
that this translates in more RV failure and ultimately worse 
outcomes may serve as an extra argument to screen for and 
treat elevated ﬁlling pressures.
Study Limitations
This study has several limitations. First, it is a retrospective 
study with well-known inherent limitations. Second, we arbi-
trarily deﬁned a reasonable time frame with regard to clini-
cal, laboratory, and echocardiographic data in relation to the 
catheterization procedure. Third, there are currently no gold 
standard for RV dysfunction, and in our paper this was adju-
dicated by a very crude visual echocardiographic assessment, 
while other commonly described echocardiographic estimates 
of RV function (such as tricuspid annular plane systolic excur-
sion) were not available. However, if incorrectly done it would 
likely attenuate the association with RV afterload measures 
and therefore weaken our results. Moreover, despite the rough 
nature of this assessment, RV failure remained one of the 
strongest prognostic factors, even after multivariate adjust-
ment. We were also unable to determine whether treatment 
that does not directly alter pulmonary vascular tone has any 
effect on PAC because treatment goals of reducing PCWP 
were achieved by a variety of medications and procedures. 
Finally, the hemodynamic values were obtained from the elec-
tronic medical record because original tracings were not avail-
able for retrospective analyses, and oxygen consumption rates 
were assumed rather than measured. Nevertheless, we believe 
that the high standard of care in a catheterization laboratory 
run by cardiologists specialized in heart failure should limit 
misinterpretation or inaccuracy in measurements.
Conclusion
We conclude that in heart failure with reduced ejection frac-
tion, RV afterload is best represented by PAC because this 
measure combines a hyperbolic inverse relationship with 
PVR with a linear inverse relation with wedge pressure. These 
properties account for its superior predictive ability. PAC is an 
independent predictor of all-cause mortality and heart trans-
plantation in this patient group and is modiﬁable by therapy. 
Further prospective studies are needed to determine the practi-
cal utility and implications of this ﬁnding.
Figure 4. PAC, PVR, and τ before and after treatment for acute decompensated heart failure. A, PVR and PAC before (open box) and 
after treatment (closed box). Because PCWP decreases, the shift in PVR and PAC does not completely follow the original hyperbola. B, 
Pulmonary arterial time constant increases in patients whose PCWP decreases (>10 mm Hg) during treatment. PAC indicates pulmonary 
arterial capacitance; PVR, pulmonary vascular resistance; PCWP, pulmonary capillary wedge pressure.
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CLINICAL PERSPECTIVE
In heart failure with reduced ejection fraction, right ventricular afterload is difﬁcult to quantify and appreciate. Pulmonary 
arterial capacitance (PAC) is an integrated measure of right ventricular afterload that combines a hyperbolic inverse relation-
ship with pulmonary vascular resistance with a linear inverse relation with wedge pressure. In our large series of patients 
with advanced heart failure, we observed incremental prognostic value of PAC reduction with adverse long-term outcomes, 
and improvement in PAC after vasodilator therapy in decompensated states. These ﬁndings validated the clinical relevance 
of PAC, and support the evolving concept of reserve in right ventricular forward ﬂow that may provide a more integrated 
view of ventricular interdependence at the bedside. Improvement in PAC with vasodilator therapy further illustrates the 
importance of maintaining or improving PAC rather than simply focusing on lowering either pressure or resistance.
Post-print standardized by MSL Academic Endeavors, the imprint of the Michael Schwartz Library at Cleveland State University, 2017 
